# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-102963
Filing Date
2025-08-05
Accepted
2025-08-05 16:00:22
Documents
61
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | glto-20250630.htm iXBRL | 10-Q | 1872145
2 | EX-31.1 | glto-ex31_1.htm | EX-31.1 | 20808
3 | EX-31.2 | glto-ex31_2.htm | EX-31.2 | 20846
4 | EX-32.1 | glto-ex32_1.htm | EX-32.1 | 17609
| Complete submission text file | 0000950170-25-102963.txt |  | 6595768

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | glto-20250630.xsd | EX-101.SCH | 931945
64 | EXTRACTED XBRL INSTANCE DOCUMENT | glto-20250630_htm.xml | XML | 984469

Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39655 | Film No.: 251184701
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)